RICHMOND, Va.--(BUSINESS WIRE)--Dec. 6, 2016--
Altria Group, Inc. (Altria) (NYSE:MO) notes that Philip Morris
International Inc. (PMI) today announced the submission of a Modified
Risk Tobacco Product (MRTP) application for an electronically heated
tobacco product with the U.S. Food and Drug Administration’s (FDA)
Center for Tobacco Products. FDA will now determine whether to accept
the application for substantive review. Upon regulatory authorization by
the FDA, Altria’s companies have an exclusive license to sell this
heated tobacco product in the United States.
Altria’s wholly-owned subsidiaries include Philip Morris USA Inc., U.S.
Smokeless Tobacco Company LLC, John Middleton Co., Nu Mark LLC, Ste.
Michelle Wine Estates Ltd. (Ste. Michelle) and Philip Morris Capital
Corporation. Altria holds an equity investment in Anheuser-Busch InBev
The brand portfolios of Altria’s tobacco operating companies include Marlboro®,
Black & Mild®, Copenhagen®, Skoal®,
MarkTen® and Green Smoke®. Ste. Michelle
produces and markets premium wines sold under various labels, including Chateau
Ste. Michelle®, Columbia Crest®, 14 Hands®
and Stag’s Leap Wine Cellars™, and it imports and markets Antinori®,
Champagne Nicolas Feuillatte™, Torres® and Villa
Maria Estate™ products in the United States. Trademarks and
service marks related to Altria referenced in this release are the
property of Altria or its subsidiaries or are used with permission. More
information about Altria is available at altria.com and on the Altria
View source version on businesswire.com: http://www.businesswire.com/news/home/20161206005784/en/
Source: Altria Group, Inc.
Altria Client Services